Manufacturers report positive data for cantharidin for molluscum contagiosum

In the pivotal Phase III CAMP trials for molluscum contagiosum, complete clearance rates for baseline and new upper and lower extremity lesions were significantly improved for this terpenoid delivered via a single-use applicator as compared to vehicle.

Source:

Biospace Inc.